Lipid-based formulations of amphotericin B

被引：17
|
作者：
Plotnick, AN [1 ]
机构：
[1] Amer Soc Prevent Cruelty Anim, New York, NY 10128 USA
来源：
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION | 2000年 / 216卷 / 06期
关键词：
D O I：
10.2460/javma.2000.216.838
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
[No abstract available]
引用
收藏
页码：838 / 841
页数：4
相关论文
共 50 条
  • [41] Current development of a lipid-based nanocochleates containing Amphotericin B for oral administration
    Ji, Changxue
    Qiu, Zeliang
    Yang, Zhiwen
    Luo, Ping
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 92
  • [42] Practice guidelines for lipid-based amphotericin B in stem cell transplant recipients
    Quilitz, RE
    Arnold, AD
    Briones, GR
    Dix, SP
    Ippoliti, C
    Kennedy, LD
    Lucich, JL
    Mehta, J
    Peters, BG
    Tice, DS
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (02) : 206 - 216
  • [43] The changing epidemiology of fungal infections: Are the lipid-based forms of amphotericin B an advance?
    Herbrecht, R
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1996, 56 : 12 - 17
  • [44] Lipid formulations of amphotericin
    Botero, Martha C.
    Puentes-Herrera, Marcela
    Cortes, Jorge A.
    REVISTA CHILENA DE INFECTOLOGIA, 2014, 31 (05): : 518 - 527
  • [45] Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia
    Johansen, Helle Krogh
    Gotzsche, Peter C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (09):
  • [46] Lipid-based formulations for intestinal lymphatic delivery
    O'Driscoll, CM
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 15 (05) : 405 - 415
  • [47] Application of Lipid-Based Formulations in Drug Discovery
    Chen, Xue-Qing
    Gudmundsson, Olafur S.
    Hageman, Michael J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (18) : 7945 - 7956
  • [48] Preparation and evaluation of ibrutinib lipid-based formulations
    Song, Ping
    Tian, Yuan
    Hao, Guizhou
    Xu, Lisa
    Sun, Yan
    Sun, Yong
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 77
  • [49] Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS®), with commercial lipid-based formulations
    Fukui, H
    Koike, T
    Nakagawa, T
    Saheki, A
    Sonoke, S
    Tomii, Y
    Seki, J
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 267 (1-2) : 101 - 112
  • [50] Lipid formulations of amphotericin B: Clinical efficacy and toxicities
    Wong-Beringer, A
    Jacobs, RA
    Guglielmo, BJ
    CLINICAL INFECTIOUS DISEASES, 1998, 27 (03) : 603 - 618
12345